Showing posts with label APAC. Show all posts
Showing posts with label APAC. Show all posts

Monday, 8 June 2020

APAC to Witness Robust Growth in Rapid Test Kit Market until 2025 – TechSci Research

Growing demand for personalized care to drive the growth of global rapid test kit market
According to TechSci Research report, Global Rapid Test Kit Market By Type (Rapid Antigen Test v/s Rapid Antibody Test), By Product Type (Over-the-counter (OTC) Rapid Test Kit v/s Professional Rapid Test Kit), By Technology (Lateral Flow Assays, Flow Through, Agglutination, Immunospot Assay, Immunochromatographic Assay, Solid Phase), By Duration (Less than 10 minutes, Less than 30 minutes, Less than 1 hour, 1 hour-2 hour, Others), By Application (Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, Others), By End Users (Hospitals & Clinics, Diagnostic Centers, Public Health Labs, Private or Commercial Labs, Physician Labs, Home Care, Others), By Region, Forecast & Opportunities, 2025the global rapid test kit market is expected to grow at a formidable rate during the forecast period on account of the widespread adoption of these kits across major healthcare facilities. Additionally, growing popularity of preliminary screening procedures is further expected to propel the market growth through 2025. Furthermore, growing prevalence of different diseases has led to an increase in demand for diagnostic tests, thereby fueling the market growth over the next few years. Besides, increasing healthcare costs are further expected to increase the demand for affordable rapid testing procedures. Also, increasing use of rapid test kits in food & beverage industry for food testing applications and prevention of food borne diseases, is further expected to spur the market growth. Moreover, increasing investment on R&D and new product launches by the major biotechnology and pharmaceutical giants is expected to create lucrative opportunities for the market growth. Also, dynamic marketing and advertising policies followed by major market players, especially for glucose monitoring and pregnancy kits, is further expected to drive the market growth. However, stringent regulatory norms for the approval of test kits might hamper the market growth through 2025. Also, sometimes a few test kits are called back since they deliver false results. This is also expected to restrict the market growth during the forecast period. Furthermore, lack of awareness especially in the emerging world might further impede the market growth. Additionally, these are good for preliminary screening or tests but cannot be completely relied upon. Hence, confirmatory or secondary tests are required after using rapid test kits.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on
" Global Rapid Test Kit Market"
https://www.techsciresearch.com/report/rapid-test-kit-market/4858.html
The global rapid test kit market is segmented based on type, product type, technology, duration, application, end users, company and region. Based on product type, the marker can be split into over-the-counter (OTC) rapid test kit and professional rapid test kit. Among these, the over-the-counter (OTC) rapid test kit segment is expected to grow significantly through 2025 due to the growing prevalence of chronic diseases such as diabetes. Based on application, the market can be fragmented into infectious disease, cardiology, oncology, pregnancy & fertility, toxicology, glucose monitoring, and others. Here, the infectious disease segment is further categorized into COVID-19, SERS, MERS, influenza, flu and others. Among these, the infectious disease segment is expected to dominate the market owing to the widespread use of these kits in preliminary screening of various infectious diseases such as hepatitis, HIV, among others. Furthermore, sudden outbreak of pandemic novel coronavirus disease has increased the demand for rapid test kits for screening and identifying the positive and suspected coronavirus cases.
Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Global BioDiagnostics Corporation, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Cepheid, Inc., Eurofins, Luminex Corporation, PerkinElmer, Cellex Inc, Merieux NutriSciences, Qiagen Company, Mesa Biotech, BioFire Diagnostics and others are some of the leading players operating in global rapid test kit market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share.
Customers can also request for 10% free customization on this report.
“Asia-Pacific is expected to register the highest growth in the global rapid test kits market owing to the increasing patient pool in the region suffering from various chronic and infectious diseases. Additionally, increasing healthcare awareness has led to an increase in the R&D activities especially in countries such as China, India and Japan. Furthermore, increasing international trade is expected to create lucrative opportunities for the market growth. Also, major market players are expanding their facilities in the region owing to the availability of low cost manufacturing and labor, thereby creating more growth opportunities in the region.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Global Rapid Test Kit Market By Type (Rapid Antigen Test v/s Rapid Antibody Test), By Product Type (Over-the-counter (OTC) Rapid Test Kit v/s Professional Rapid Test Kit), By Technology (Lateral Flow Assays, Flow Through, Agglutination, Immunospot Assay, Immunochromatographic Assay, Solid Phase), By Duration (Less than 10 minutes, Less than 30 minutes, Less than 1 hour, 1 hour-2 hour, Others), By Application (Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, Others), By End Users (Hospitals & Clinics, Diagnostic Centers, Public Health Labs, Private or Commercial Labs, Physician Labs, Home Care, Others), By Region, Forecast & Opportunities, 2025”, has evaluated the future growth potential of global rapid test kit market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global rapid test kit market.

Friday, 1 November 2019

iQuanti Expands its Global Presence by Foraying into the APAC Region


With the rapid mobile-led digital adoption in the region and rising advertiser interest in all things digital, iQuanti, a data science and SaaS products driven digital marketing firm has placed its bets on the APAC region to contribute a significant component of its future revenues. US-based iQuanti is already disrupting the large traditional agency players in the United States through its data-science led products that drive superior growth and efficiency in digital. iQuanti within a few years of existence is already working with several Fortune 500 brands in the US. 
iQuanti's expansion to the APAC region is part of the company's strategic vision to expand globally. With the rapid economic growth in the APAC region, nearly 34% of the global digital advertising revenue is likely to be generated from the APAC region by 2020 and ad-spends on digital marketing in the region are outpacing spending on TV advertising. 
iQuanti is already working with some of the large regional banks and eCommerce players in Australia, Singapore, and India. With specific growth investments in the region, iQuanti is now fast-tracking its penetration strategy for the region.
iQuanti is rapidly building its customer success and solutions teams in the region to activate its growth plans. Meanwhile, globally, iQuanti's patented enterprise search channel platform ALPS was named the second-best search software in the U.S by the Drum Search Awards in 2018. ALPS uses proprietary data science and machine learning models to build predictive enterprise-level roadmaps that deliver strong ROI. iQuanti has also featured in the 2019 Inc. list of fastest-growing private companies in the US, for a record fifth time.